|
US6908910B2
(en)
|
1993-08-06 |
2005-06-21 |
The Children's Medical Center Corporation |
Estrogenic compounds as anti-mitotic agents
|
|
US20040214807A1
(en)
*
|
1993-08-06 |
2004-10-28 |
D'amato Robert J. |
Estrogenic compounds as anti-mitotic agents
|
|
US5504074A
(en)
*
|
1993-08-06 |
1996-04-02 |
Children's Medical Center Corporation |
Estrogenic compounds as anti-angiogenic agents
|
|
US6346510B1
(en)
*
|
1995-10-23 |
2002-02-12 |
The Children's Medical Center Corporation |
Therapeutic antiangiogenic endostatin compositions
|
|
AU2103097A
(en)
*
|
1996-03-15 |
1997-10-10 |
Zeneca Limited |
Cinnoline derivatives and use as medicine
|
|
GB9707800D0
(en)
|
1996-05-06 |
1997-06-04 |
Zeneca Ltd |
Chemical compounds
|
|
CA2263479A1
(en)
|
1996-09-25 |
1998-04-02 |
Zeneca Limited |
Quinoline derivatives inhibiting the effect of growth factors such as vegf
|
|
GB9718972D0
(en)
|
1996-09-25 |
1997-11-12 |
Zeneca Ltd |
Chemical compounds
|
|
ATE368665T1
(de)
|
1997-08-22 |
2007-08-15 |
Astrazeneca Ab |
Oxindolylchinazolinderivate als angiogenesehemmer
|
|
US20020002294A1
(en)
*
|
1997-09-24 |
2002-01-03 |
D' Amato Robert J. |
Estrogenic compounds as antiangiogenic agents
|
|
AU5620299A
(en)
|
1998-08-11 |
2000-03-06 |
Novartis Ag |
Isoquinoline derivatives with angiogenesis inhibiting activity
|
|
ATE371453T1
(de)
*
|
1998-08-13 |
2007-09-15 |
Novartis Pharma Gmbh |
Verfahren zur behandlung von okularen neovaskularen erkrankungen
|
|
UA71971C2
(en)
|
1999-06-04 |
2005-01-17 |
Agoron Pharmaceuticals Inc |
Diaminothiazoles, composition based thereon, a method for modulation of protein kinases activity, a method for the treatment of diseases mediated by protein kinases
|
|
PE20010306A1
(es)
*
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
|
US7141581B2
(en)
|
1999-07-02 |
2006-11-28 |
Agouron Pharmaceuticals, Inc. |
Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
|
|
TWI262914B
(en)
|
1999-07-02 |
2006-10-01 |
Agouron Pharma |
Compounds and pharmaceutical compositions for inhibiting protein kinases
|
|
US6271233B1
(en)
|
1999-08-10 |
2001-08-07 |
Ciba Vision Corporation |
Method for treating ocular neovascular diseases
|
|
US7087592B1
(en)
*
|
1999-08-23 |
2006-08-08 |
Entre Med, Inc. |
Compositions comprising purified 2-methoxyestradiol and methods of producing same
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
HU229414B1
(hu)
|
1999-11-05 |
2013-12-30 |
Astrazeneca Ab |
Kinazolin-származékok mint VEGF-inhibitorok, eljárás az elõállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
|
|
YU54202A
(sh)
|
2000-01-18 |
2006-01-16 |
Agouron Pharmaceuticals Inc. |
Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
|
|
HN2001000008A
(es)
|
2000-01-21 |
2003-12-11 |
Inc Agouron Pharmaceuticals |
Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo
|
|
SK12712002A3
(sk)
|
2000-02-07 |
2003-02-04 |
Abbott Gmbh & Co. Kg |
Deriváty 2-benzotiazolylmočoviny a ich použitie ako inhibítorov proteínkináz
|
|
WO2001058899A1
(en)
*
|
2000-02-09 |
2001-08-16 |
Novartis Ag |
Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
|
|
DE60112268T2
(de)
*
|
2000-03-06 |
2006-05-24 |
Astrazeneca Ab |
Verwendung von quinazolinderivate als inhibitoren der angiogenese
|
|
GB0008269D0
(en)
*
|
2000-04-05 |
2000-05-24 |
Astrazeneca Ab |
Combination chemotherapy
|
|
CN1240688C
(zh)
*
|
2000-04-07 |
2006-02-08 |
阿斯特拉曾尼卡有限公司 |
喹唑啉化合物
|
|
AU2001249865A1
(en)
|
2000-04-18 |
2001-10-30 |
Agouron Pharmaceuticals, Inc. |
Pyrazoles for inhibiting protein kinase
|
|
US20050192258A1
(en)
*
|
2000-08-18 |
2005-09-01 |
Agoston Gregory E. |
Antiangiogenic agents
|
|
US6995278B2
(en)
*
|
2000-08-18 |
2006-02-07 |
Entre Med, Inc. |
Antiangiogenic agents
|
|
BR0113258A
(pt)
|
2000-08-18 |
2003-07-15 |
Agouron Pharma |
Compostos, pró-drogas, metabólitos ou sais, métodos de tratamento de condição doentia em mamìferos, mediada pela atividade de proteìna cinase e métodos de modulação ou inibição da atividade de um receptor de proteìna cinase
|
|
US7135581B2
(en)
*
|
2000-08-18 |
2006-11-14 |
Entremed, Inc. |
Antiangiogenic agents
|
|
JP4341949B2
(ja)
|
2000-09-01 |
2009-10-14 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
アザ複素環式誘導体およびその治療的使用
|
|
CN100351249C
(zh)
|
2000-09-11 |
2007-11-28 |
希龙公司 |
作为酪氨酸激酶抑制剂的喹啉酮衍生物
|
|
MXPA03008560A
(es)
|
2001-03-22 |
2004-06-30 |
Abbot Gmbh & Co Kg |
Pirazolopirimidinas como agentes terapeuticos.
|
|
HN2002000156A
(es)
|
2001-07-06 |
2003-11-27 |
Inc Agouron Pharmaceuticals |
Derivados de benzamida tiazol y composiciones farmaceuticas para inhibir la proliferacion de celulas y metodos para su utilización.
|
|
US20030187076A1
(en)
*
|
2002-01-30 |
2003-10-02 |
Agoston Gregory E. |
Non-steroidal analogs of 2-methoxyestradiol
|
|
UA81619C2
(ru)
|
2002-02-01 |
2008-01-25 |
Астразенека Аб |
Хиназолиновые соединения, способ их получения (варианты), фармацевтическая композиция на их основе
|
|
UA77303C2
(en)
|
2002-06-14 |
2006-11-15 |
Pfizer |
Derivatives of thienopyridines substituted by benzocondensed heteroarylamide useful as therapeutic agents, pharmaceutical compositions and methods for their use
|
|
EP2277867B1
(en)
|
2002-07-15 |
2012-12-05 |
Symphony Evolution, Inc. |
Compounds, pharmaceutical compositions thereof and their use in treating cancer
|
|
US7825132B2
(en)
|
2002-08-23 |
2010-11-02 |
Novartis Vaccines And Diagnostics, Inc. |
Inhibition of FGFR3 and treatment of multiple myeloma
|
|
WO2004018419A2
(en)
|
2002-08-23 |
2004-03-04 |
Chiron Corporation |
Benzimidazole quinolinones and uses thereof
|
|
PL215161B1
(pl)
*
|
2002-11-04 |
2013-10-31 |
Astrazeneca Ab |
Pochodne chinazoliny, sposób ich wytwarzania, kompozycje farmaceutyczne je zawierajace oraz ich zastosowanie
|
|
US7268137B2
(en)
*
|
2002-11-07 |
2007-09-11 |
Campochiaro Peter A |
Ocular therapy
|
|
KR20110108404A
(ko)
|
2002-11-13 |
2011-10-05 |
노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 |
암을 치료하는 방법 및 관련 방법
|
|
SI1585743T1
(sl)
|
2002-12-19 |
2007-08-31 |
Pfizer |
Spojine 2-(1H-indazol-6-ilamino)-benzamida kot inhibitorji protein-kinaz, uporabnih pri zdravljenju očesnih bolezni
|
|
JP2006526025A
(ja)
*
|
2003-05-28 |
2006-11-16 |
エントレメッド インコーポレイテッド |
抗血管新生剤
|
|
CN1934255B
(zh)
|
2003-08-27 |
2012-07-11 |
奥普索特克公司 |
用于治疗眼新血管疾病的组合治疗
|
|
MXPA06002296A
(es)
|
2003-08-29 |
2006-05-22 |
Pfizer |
Tienopiridina-fenilacetamidas y sus derivados utiles como nuevos agentes antiangiogenicos.
|
|
PL2392565T3
(pl)
|
2003-09-26 |
2014-08-29 |
Exelixis Inc |
Modulatory c-Met i sposoby stosowania
|
|
CA2542481A1
(en)
*
|
2003-10-15 |
2005-04-28 |
Osi Pharmaceuticals, Inc. |
Imidazopyrazine tyrosine kinase inhibitors
|
|
KR20060111520A
(ko)
|
2003-11-07 |
2006-10-27 |
카이론 코포레이션 |
Ｆｇｆｒ3의 억제 및 다발성 골수종의 치료
|
|
WO2005051942A1
(en)
|
2003-11-19 |
2005-06-09 |
Signal Pharmaceuticals, Llc |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
|
RU2377988C2
(ru)
|
2004-02-20 |
2010-01-10 |
Новартис Вэксинес Энд Дайэгностикс, Инк. |
Модуляция воспалительных и метастатических процессов
|
|
WO2005089256A2
(en)
*
|
2004-03-12 |
2005-09-29 |
Entremed, Inc. |
Antiangiogenic agents
|
|
US20070004689A1
(en)
*
|
2004-03-12 |
2007-01-04 |
Agoston Gregory E |
Antiangiogenic agents
|
|
MXPA06011423A
(es)
|
2004-04-02 |
2007-01-23 |
Osi Pharm Inc |
Inhibidores de proteina cinasa heterobiciclica sustituida en el anillo 6,6-biciclico.
|
|
MY139689A
(en)
|
2004-07-20 |
2009-10-30 |
Osi Pharm Inc |
Imidazotriazines as protein kinase inhibitors
|
|
WO2006028957A1
(en)
*
|
2004-09-03 |
2006-03-16 |
Memory Pharmaceuticals Corporation |
4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
|
|
BRPI0518158A
(pt)
|
2004-10-14 |
2008-11-04 |
Hoffmann La Roche |
tiazolinonas de azaindol como agentes anti-cáncer
|
|
US20060116360A1
(en)
*
|
2004-11-29 |
2006-06-01 |
Fogler William E |
Method of administering anti-angiogenic agents and a method of treating disease using same
|
|
EP1833803A4
(en)
*
|
2005-01-03 |
2009-08-05 |
Myriad Genetics Inc |
PHARMACEUTICAL COMPOUNDS AS ACTIVATORS OF CASPASES AND INDUCTORS OF APOPTOSIS AND THEIR USE
|
|
DOP2006000051A
(es)
|
2005-02-24 |
2006-08-31 |
Lilly Co Eli |
Inhibidores de vegf-r2 y métodos
|
|
US7304074B2
(en)
|
2005-04-05 |
2007-12-04 |
Hoffmann-La Roche Inc. |
Substituted 1,5-naphthyridine azolinones
|
|
US20060264439A1
(en)
*
|
2005-05-17 |
2006-11-23 |
Supergen, Inc. |
Inhibitors of polo-like kinase-1
|
|
ES2376347T3
(es)
|
2005-05-17 |
2012-03-13 |
Novartis Ag |
Métodos para sintetizar compuestos heteroc�?clicos.
|
|
CA2609353C
(en)
|
2005-05-23 |
2015-04-28 |
Novartis Ag |
Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactic acid salts
|
|
US7566721B2
(en)
*
|
2005-08-08 |
2009-07-28 |
Osi Pharmaceuticals, Inc. |
Substituted thienol[2,3-d]pyrimidines as kinase inhibitors
|
|
WO2007059111A2
(en)
*
|
2005-11-14 |
2007-05-24 |
Entremed, Inc. |
Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
|
|
TW200730176A
(en)
|
2005-11-29 |
2007-08-16 |
Novartis Ag |
Formulations of quinolinones
|
|
AR057960A1
(es)
*
|
2005-12-02 |
2007-12-26 |
Osi Pharm Inc |
Inhibidores de proteina quinasa biciclicos
|
|
US8575164B2
(en)
*
|
2005-12-19 |
2013-11-05 |
OSI Pharmaceuticals, LLC |
Combination cancer therapy
|
|
US20070176403A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Dennis Calderone |
Air adjustable seat
|
|
CA2646065C
(en)
*
|
2006-03-20 |
2014-01-14 |
Entremed, Inc. |
Disease modifying anti-arthritic activity of 2-methoxyestradiol
|
|
US20070258976A1
(en)
*
|
2006-05-04 |
2007-11-08 |
Ward Keith W |
Combination Therapy for Diseases Involving Angiogenesis
|
|
US20080234243A1
(en)
*
|
2007-01-31 |
2008-09-25 |
Lavallee Theresa M |
Method of treating amyloidosis mediated diseases
|
|
US20080190689A1
(en)
*
|
2007-02-12 |
2008-08-14 |
Ballard Ebbin C |
Inserts for engine exhaust systems
|
|
JP2011510018A
(ja)
*
|
2008-01-18 |
2011-03-31 |
オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド |
癌治療のためのイミダゾピラジノール誘導体
|
|
WO2009143051A1
(en)
*
|
2008-05-19 |
2009-11-26 |
Osi Pharmaceuticals, Inc. |
Substituted imidazopyr-and imidazotri-azines
|
|
TWI511956B
(zh)
|
2009-01-16 |
2015-12-11 |
Exelixis Inc |
製備ｎ-（４-｛〔６，７-雙（甲氧基）喹啉-４-基〕氧基｝苯基）-ｎ’-（４-氟苯基）環丙烷-１，１-二甲醯胺之方法
|
|
KR20120020099A
(ko)
|
2009-04-20 |
2012-03-07 |
오에스아이 파마슈티컬스, 엘엘씨 |
Ｃ-피라진-메틸아민의 제조
|
|
EP2427192A1
(en)
*
|
2009-05-07 |
2012-03-14 |
OSI Pharmaceuticals, LLC |
Use of osi-906 for treating adrenocortical carcinoma
|
|
UA108618C2
(uk)
|
2009-08-07 |
2015-05-25 |
|
Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
|
|
US20110189174A1
(en)
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
|
US10968290B2
(en)
|
2017-03-28 |
2021-04-06 |
Exxonmobil Chemical Patents Inc. |
Metallocene-catalyzed polyalpha-olefins
|
|
US11078308B2
(en)
|
2018-02-12 |
2021-08-03 |
Exxonmobil Chemical Patents Inc. |
Processes to produce poly alpha-olefin trimers
|
|
US11084894B2
(en)
|
2018-02-12 |
2021-08-10 |
Exxonmobil Chemical Patents Inc. |
Catalyst systems and processes for poly alpha-olefin having high vinylidene content
|
|
US11021553B2
(en)
|
2018-02-12 |
2021-06-01 |
Exxonmobil Chemical Patents Inc. |
Metallocene dimer selective catalysts and processes to produce poly alpha-olefin dimers
|
|
EP3784648B1
(en)
|
2018-04-26 |
2025-07-02 |
ExxonMobil Chemical Patents Inc. |
Non-coordinating anion type activators containing cation having branched alkyl groups
|
|
US11059791B2
(en)
|
2019-04-25 |
2021-07-13 |
Exxonmobil Chemical Patents Inc. |
Non-coordinating anion type benzimidazolium activators
|
|
US12344696B2
(en)
|
2019-08-09 |
2025-07-01 |
Exxonmobil Chemical Patents Inc. |
Process to produce low viscosity polyalphaolefins using non-aromatic-hydrocarbon soluble activators
|
|
CN112694474B
(zh)
*
|
2019-10-23 |
2022-03-18 |
四川大学 |
吲唑类衍生物及其制备方法和用途
|
|
WO2021086926A1
(en)
|
2019-10-28 |
2021-05-06 |
Exxonmobil Chemical Patents Inc. |
Dimer selective metallocene catalysts, non-aromatic hydrocarbon soluble activators, and processes to produce poly alpha-olefin oligmers therewith
|
|
US11572423B2
(en)
|
2019-12-11 |
2023-02-07 |
Exxonmobil Chemicals Patents Inc. |
Processes for introduction of liquid activators in olefin polymerization reactions
|
|
US11584707B2
(en)
|
2019-12-16 |
2023-02-21 |
Exxonmobil Chemical Patents Inc. |
Non-coordinating anion type activators containing cation having aryldiamine groups and uses thereof
|
|
EP4110834B1
(en)
|
2020-02-24 |
2024-04-03 |
ExxonMobil Chemical Patents Inc. |
Ansa-bis(inden-2-yl) catalysts for producing vinylidene-terminated polyalphaolefins
|
|
US11746163B2
(en)
|
2021-01-05 |
2023-09-05 |
Exxonmobil Chemical Patents Inc. |
Isohexane-soluble unsaturated alkyl anilinium tetrakis(perfluoroaryl)borate activators
|
|
CN119638634A
(zh)
*
|
2023-09-18 |
2025-03-18 |
上海赛默罗生物科技有限公司 |
噌啉-2-氧化物类化合物及其制备方法和用途
|